<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV)-harboring non-producer Raji cells were activated to express Epstein-Barr virus early antigen (EA) by the combined use of <z:chebi fb="0" ids="17968">n-butyrate</z:chebi> and various <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoters such as 12-O-<z:chebi fb="0" ids="25456">tetradecanoyl</z:chebi> <z:chebi fb="0" ids="45127">phorbol-13-acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>), Euphorbiaceae plant extracts and the toxic microbial metabolite, teleocidin </plain></SENT>
<SENT sid="1" pm="."><plain>With regard to the structural differences among the inducing agents (promoters), the patterns of EBV early <z:chebi fb="1" ids="15841">polypeptides</z:chebi> were strikingly similar </plain></SENT>
<SENT sid="2" pm="."><plain>A common pathway is probably involved in the activation of the latent genomes of the virus in the host cells </plain></SENT>
</text></document>